May. 5 at 8:25 PM
$USNA Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of
$0.41 down -16.33% YoY
• Reported revenue of
$250.22M up 0.27% YoY
• Usana Health Sciences Inc. is reiterating its fiscal year 2026 outlook, projecting consolidated net sales between
$925 million and
$1.0 billion, with diluted EPS expected to range from
$1.11 to
$1.45.